BRCA1-mutated patients have a lifetime risk of developing BC of 65% and an ovarian cancer risk of 39%, while the risk of BC is 45% and the risk of ovarian cancer is 17% in BRCA2-mutated patients [26]. This evidence concerns the gene BRCA2 and ovarian cancer.